OSTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OS Therapies Inc (OSTX) is not a strong buy at the moment for a beginner investor with a long-term horizon. The stock shows no clear technical or proprietary trading signals, and there is a lack of significant positive catalysts or financial data to support a confident investment decision. While analysts maintain a Buy rating, the lowered price targets and lack of recent news or influential trading activity suggest a cautious approach.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 69.986, and moving averages are converging, showing no clear trend. The stock is trading near its R1 resistance level of 1.908, with key support at 1.78. Overall, the technical indicators do not suggest a strong entry point.
Analysts maintain a Buy rating, and upcoming 2.5-year overall survival data release at ASCO could act as a potential catalyst.
Lowered price targets by analysts due to recent dilution and balance sheet repositioning. Lack of significant trading trends, insider activity, or recent news.
No financial data available for analysis.
Lake Street maintains a Buy rating but has lowered the price target twice recently, from $17 to $14 and then to $13, reflecting dilution and balance sheet repositioning.
